Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey

Author:

Neoh Chin Fen¹^ORCID,Senol Esin²,Kara Ates³,Dinleyici Ener Cagri⁴^ORCID,Turner Stuart J.⁵,Kong David C. M.⁶⁷^ORCID

Affiliation:

1. Collaborative Drug Discovery Research (CDDR) Group; Faculty of Pharmacy; Universiti Teknologi MARA; Puncak Alam Malaysia

2. Department of Infectious Diseases; Gazi University; Ankara Turkey

3. Department of Paediatric Infectious Diseases; Hacettepe University; Ankara Turkey

4. Department of Paediatrics; Faculty of Medicine; Eskisehir Osmangazi University; Eskisehir Turkey

5. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

6. Centre for Medicine Use and Safety; Faculty of Pharmacy and Pharmaceutical Sciences; Monash University; Parkville VIC Australia

7. Pharmacy Department; Ballarat Health Services; Ballarat VIC Australia

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

Reference40 articles.

1. Invasive Candidiasis;McCarty;Infect Dis Clin North Am,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献